Abstract
Neuronal dysfunction has been extensively studied as a central feature of neurodegenerative tauopathies. However, across neurodegenerative diseases, there is strong evidence for active involvement of immune cells like microglia in driving disease pathophysiology. Here, we demonstrate that tau mRNA and protein are expressed in microglia in human brains and in human induced pluripotent stem cell (iPSC)-derived microglia like cells (iMGLs). Using iMGLs harboring the MAPT IVS10+16 mutation and isogenic controls, we demonstrate that a tau mutation is sufficient to alter microglial transcriptional states. We discovered that MAPT IVS10+16 microglia exhibit cytoskeletal abnormalities, stalled phagocytosis, disrupted TREM2/TYROBP networks, and altered metabolism. Additionally, we found that secretory factors from MAPT IVS10+16 iMGLs impact neuronal health, reducing synaptic density in neurons. Key features observed in vitro were recapitulated in human brain tissue and cerebrospinal fluid from MAPT mutations carriers. Together, our findings that MAPT IVS10+16 drives cell-intrinsic dysfunction in microglia that impacts neuronal health has major implications for development of therapeutic strategies.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
GIH36 and GIH178 were provided through the generous support of the Tau Consortium of the Rainwater Charitable Foundation. We thank Steve Lotz and members of the Neuracell Core Facility, the Neural Stem Cell Institute, Rensselaer NY for generating the GIH36 and GIH178 iPSC lines. We thank the Genome Engineering & Stem Cell Center (GESC@MGI) at Washington University in St. Louis School of Medicine for iPSC reprogramming services. This work was supported by access to equipment made possible by the Hope Center for Neurological Disorders, the Neurogenomics and Informatics Center, and the Departments of Neurology and Psychiatry at Washington University School of Medicine. Confocal images were generated on a Zeiss LSM 980 Airyscan Confocal Microscope which was purchased with support from NIMH grant MH126964 and on the Nikon AXR with NSPARC through the use of Washington University Center for Cellular Imaging (WUCCI)-Neuro supported by Washington University School of Medicine, the Childrens Discovery Institute of Washington University and St. Louis Childrens Hospital (CDI-CORE-2015-505 and CDI-CORE-2019-813), and the Foundation for Barnes-Jewish Hospital (3770 and 4642). Funding provided by the National Institutes of Health (P30 AG066444, R01 AG056293, RF1 NS110890, U54 NS123985), Hope Center for Neurological Disorders (CMK), Rainwater Charitable Organization (CMK), BrightFocus Foundation (CMK), Farrell Family Fund for Alzheimers Disease (CMK), and UL1TR002345. CS is supported by National Institutes of Health (NIH)/National Institute on Aging (NIA) K01AG062796. LV is supported by grant funding and consultancy/speaker fees from ZonMw (VENI grant), Amsterdam UMC (Startergrant) Stichting Dioraphte (biobank DemenTree), Olink, Lilly, Roche; all paid to her institution. Mass spectrometry work was supported by resources and effort provided by the Tracy Family Stable Isotope Labeling Quantitation Center established by the Tracy Family, R. Frimel and G. Werths, GHR Foundation, D. Payne and the Willman Family brought together by The Foundation for Barnes-Jewish Hospital. This work was also supported by cores, resources, and effort provided by Washington University Biomedical Mass Spectrometry Research Facility (NIH/National Institute of General Medical Sciences P41 GM103422). The UCSF Neurodegenerative Disease Brain Bank receives funding support from NIH grants P30AG062422, P01AG019724, U01AG057195, and U19AG063911, as well as the Rainwater Charitable Foundation, and the Bluefield Project to Cure FTD. We would like to thank Dorjan Brinja, Pascaline Akitani, and Erica Lantelme of the Flow Cytometry & Fluorescence-Activated Cell Sorting Core supported by the Department of Pathology and Immunology at Washington University in St. Louis for their assistance with flow sorting of HPCs. Diagrams were generated using BioRender.com.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The informed consent was approved by the Washington University School of Medicine Institutional Review Board and Ethics Committee (IRB 201104178 and 201306108). The University of California San Francisco Institutional Review Board approved the operating protocols of the UCSF Neurodegenerative Disease Brain Bank (from which brain tissues were obtained). Participants or their surrogates provided consent for autopsy, in keeping with the guidelines put forth in the Declaration of Helsinki, by signing the hospital autopsy form. If the participant had not provided future consent before death, the DPOA or next of kin provided it after death. All data were analyzed anonymously.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are contained in the manuscript and/or available upon reasonable request.
